Dr. Alan Dandrea, MD

NPI: 1174599930
Total Payments
$826,972
2024 Payments
$3,438
Companies
10
Transactions
34

Payment Breakdown by Category

Other$777,500 (94.0%)
Consulting$48,289 (5.8%)
Food & Beverage$1,063 (0.1%)
Travel$120.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $777,500 4 94.0%
Consulting Fee $48,289 11 5.8%
Food and Beverage $1,063 18 0.1%
Travel and Lodging $120.00 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Eli Lilly and Company $777,500 4 $0 (2018)
EMD Serono, Inc. $17,228 12 $0 (2019)
E.R. Squibb & Sons, L.L.C. $9,671 4 $0 (2021)
EMD Serono Research & Development Institute $6,706 2 $0 (2017)
GlaxoSmithKline, LLC. $3,575 1 $0 (2021)
Bayer HealthCare Pharmaceuticals Inc. $3,500 1 $0 (2020)
ABBVIE INC. $3,438 3 $0 (2024)
Servier BioInnovation $2,720 2 $0 (2023)
AstraZeneca Pharmaceuticals LP $2,612 4 $0 (2017)
Bristol-Myers Squibb Company $22.37 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,438 3 ABBVIE INC. ($3,438)
2023 $2,720 2 Servier BioInnovation ($2,720)
2021 $4,875 2 GlaxoSmithKline, LLC. ($3,575)
2020 $3,500 1 Bayer HealthCare Pharmaceuticals Inc. ($3,500)
2019 $8,120 6 EMD Serono, Inc. ($8,120)
2018 $167,216 5 Eli Lilly and Company ($150,000)
2017 $637,103 15 Eli Lilly and Company ($627,500)

All Payment Transactions

34 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/09/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $3,383.33 General
09/12/2024 ABBVIE INC. Food and Beverage In-kind items and services $43.11 General
09/12/2024 ABBVIE INC. Food and Beverage In-kind items and services $11.60 General
09/19/2023 Servier BioInnovation Consulting Fee Cash or cash equivalent $1,700.00 General
06/20/2023 Servier BioInnovation Consulting Fee Cash or cash equivalent $1,020.00 General
10/06/2021 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $1,300.00 General
09/22/2021 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $3,575.00 General
05/11/2020 Bayer HealthCare Pharmaceuticals Inc. Non-Covered Consulting Fee Cash or cash equivalent $3,500.00 General
06/11/2019 EMD Serono, Inc. Consulting Fee Cash or cash equivalent $7,800.00 General
05/07/2019 EMD Serono, Inc. Food and Beverage In-kind items and services $69.13 General
05/07/2019 EMD Serono, Inc. Food and Beverage In-kind items and services $46.28 General
05/07/2019 EMD Serono, Inc. Food and Beverage In-kind items and services $32.96 General
05/07/2019 EMD Serono, Inc. Food and Beverage In-kind items and services $32.96 General
05/06/2019 EMD Serono, Inc. Food and Beverage In-kind items and services $138.60 General
10/29/2018 Eli Lilly and Company Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $150,000.00 General
07/19/2018 EMD Serono, Inc. Consulting Fee Cash or cash equivalent $8,845.00 General
03/01/2018 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $8,050.00 General
02/14/2018 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $201.38 General
02/14/2018 E.R. Squibb & Sons, L.L.C. Travel and Lodging Cash or cash equivalent $120.00 General
12/19/2017 Bristol-Myers Squibb Company Food and Beverage Cash or cash equivalent $22.37 General
06/25/2017 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Consulting Fee Cash or cash equivalent $2,416.00 General
Category: Oncology
06/12/2017 Eli Lilly and Company Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $213,750.00 General
06/01/2017 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $101.95 General
06/01/2017 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $65.00 General
06/01/2017 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $28.68 General

About Dr. Alan Dandrea, MD

Dr. Alan Dandrea, MD is a Pediatric Hematology-Oncology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174599930.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Dandrea, MD has received a total of $826,972 in payments from pharmaceutical and medical device companies, with $3,438 received in 2024. These payments were reported across 34 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($777,500).

Practice Information

  • Specialty Pediatric Hematology-Oncology
  • Location Boston, MA
  • Active Since 02/23/2006
  • Last Updated 07/09/2007
  • Taxonomy Code 2080P0207X
  • Entity Type Individual
  • NPI Number 1174599930

Products in Payments

  • Non-Covered $3,500
  • LYNPARZA (Drug) $2,416

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Hematology-Oncology Doctors in Boston